The latest price target for Kala Bio (NASDAQ:KALA) was reported by HC Wainwright & Co. on September 29, 2025. The analyst firm set a price target for $0.00 expecting KALA to fall to within 12 months (a possible -100.00% downside). 8 analyst firms have reported ratings in the last year.

The latest analyst rating for Kala Bio (NASDAQ:KALA) was provided by HC Wainwright & Co., and Kala Bio downgraded their neutral rating.

There is no last upgrade for Kala Bio

The last downgrade for Kala Bio Inc happened on September 29, 2025 when HC Wainwright & Co. changed their price target from N/A to N/A for Kala Bio Inc.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Kala Bio, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Kala Bio was filed on September 29, 2025 so you should expect the next rating to be made available sometime around September 29, 2026.

While ratings are subjective and will change, the latest Kala Bio (KALA) rating was a downgraded with a price target of $0.00 to $0.00. The current price Kala Bio (KALA) is trading at is $0.60, which is out of the analyst’s predicted range.